| Ticker Details |
|
MIRUM PHARMACEUTICALS, INC.
|
| IPO Date: |
July 12, 2019 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$5.97B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.68 | 2.49%
|
| Avg Daily Range (30 D): |
$1.64 | 1.79%
|
| Avg Daily Range (90 D): |
$1.63 | 1.90%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.3M |
| Avg Daily Volume (30 D): |
.7M |
| Avg Daily Volume (90 D): |
.62M |
| Trade Size |
| Avg Trade Size (Sh.): |
58 |
| Avg Trade Size (Sh.) (30 D): |
47 |
| Avg Trade Size (Sh.) (90 D): |
48 |
| Institutional Trades |
| Total Institutional Trades: |
2,087 |
| Avg Institutional Trade: |
$3.18M |
| Avg Institutional Trade (30 D): |
$8.02M |
| Avg Institutional Trade (90 D): |
$7.43M |
| Avg Institutional Trade Volume: |
.07M |
| Avg Institutional Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$4M |
| Avg Closing Trade (30 D): |
$18.37M |
| Avg Closing Trade (90 D): |
$13.55M |
| Avg Closing Volume: |
88.5K |
|
|
| Financials |
| |
TTM |
Q4 2025 |
FY 2025 |
|
Basic EPS
|
$-.47
|
$-.12
|
$-.47
|
|
Diluted EPS
|
$-.47
|
$-.12
|
$-.47
|
|
Revenue
|
$521.31M
|
$148.93M
|
$521.31M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-23.36M
|
$-5.73M
|
$-23.36M
|
|
Operating Income / Loss
|
$-22.14M
|
$-4.57M
|
$-22.14M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$72.02M
|
$16.07M
|
$72.02M
|
|
PE Ratio
|
|
|
|
|
|
|